- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- No more ‘old school’: How Duke Health is reimagining workforce development
- Why private practice dentistry needs a better model
- Chief nurses: Hospital finances improve with nursing investments
- Mississippi health system goes ‘all in’ on Epic with $115M investment
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Ascension Wisconsin CEO to step down
- The hospitals, health systems cutting jobs in 2026
- The hospitals, health systems cutting jobs in 2026
- Nonprofit highlights rural opioid care strategies
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- Wearables data predicts patient engagement: Mayo Clinic study
- Advocate plans largest US hospital drone delivery network
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- Indiana system opens $21.7M outpatient center
- Trump administration targets medical school admissions: 4 notes
- EyeSouth Partners continues 2026 expansion with Louisiana practice
- RSV lingers in parts of US even as flu and COVID-19 recede
- Providence narrows operating loss to $486M in 2025
- A huge month for CMS policy
- What the Health? From KFF Health News: A Headless CDC
- GI is exploding with new tech—but how do patients feel about it?
- Maryland physician to pay $500K+ to settle false claims allegations
- Rhode Island oral surgeon launches Congressional campaign
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- Infosys to acquire Optimum Healthcare IT in $465M deal
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- St. Luke’s CFO joins RCM company’s advisory board
- 52 DSOs to know: 2026
- 10 hospitals, health systems looking for CFOs
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- 10 health system rating downgrades
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- North Star’s restructuring moves forward
- Illinois hospital pauses patient care amid payroll challenges
- What the Best-Performing Revenue Cycles Have in Common
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Medicaid work rules and enrollment losses: 6 notes
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
Michigan's official vaccine stance was never in doubt, but those who like details will enjoy today's MDHHS Press Release.
I've highlighted the core argument in bold font.
https://www.michigan.gov/mdhhs/inside-mdhhs/newsroom/2025/09/19/standing-rec
State’s Chief Medical Executive Dr. Natasha Bagdasarian makes Standing Recommendation on COVID-19 vaccines
Determines not receiving a dose of COVID-19 vaccine to be an underlying conditionLANSING, Mich. - In response to Gov. Gretchen Whitmer’s Executive Directive to state agencies to ensure Michigan families can access COVID-19 vaccines, the state’s Chief Medical Executive Dr. Natasha Bagdasarian has issued a Standing Recommendation for the COVID-19 vaccine.
“National medical organizations and scientific experts continue to recommend routine COVID-19 vaccination for those at high risk, but also recommend vaccines be made available for all those who want them, ages six months and older,” said Bagdasarian. “COVID-19 vaccines have been proven to reduce the likelihood of emergency department or urgent care visits, as well as hospitalizations and severe outcomes. They are one of our best defenses against the virus. As the state’s chief medical executive, it is my duty to protect and promote public health, and everyone deserves the opportunity to access COVID-19 vaccine if they desire one. This Standing Recommendation will help to protect vaccine accessibility and availability in our state.”
On Wednesday, Aug. 27, the U.S. Food and Drug Administration (FDA) approved the 2025-2026 vaccine for those 65 years of age and older and those ages 5 through 64 years with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. However, the FDA did not define the list of underlying conditions. The Centers for Disease Control and Prevention’s list includes conditions such as obesity and physical inactivity and states it is “not exhaustive” and “should not be used to exclude people with underlying conditions from recommended measures for prevention or treatment of COVID-19.”
In her recommendation, Bagdasarian stated, “Any person over the age of six months without contraindication who has not received a dose of a Food and Drug Administration (FDA)-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is thus eligible to receive an age-appropriate dose.”
The Michigan Department of Health and Human Services (MDHHS) continues to recommend the COVID-19 vaccine in alignment with the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists.
To help ensure insurance coverage and availability of COVID-19 vaccines as outlined in the Executive Directive, MDHHS is working with the Department of Insurance and Financial Services and the Michigan Department of Licensing and Regulatory Affairs.
To learn more about COVID-19 and seasonal respiratory illnesses and how to protect yourself, visit Michigan.gov/COVIDFluRSV.
# # #
In the game of governments and vaccine policy, looks like the ball is back in the Trump Administration's court. Any bets on Medicaid funding playing a major role?
LARA just issued the same presser under the subject line, "Sharing on behalf of MDHHS."
No other comment, but an early signal to every licensed health professional in Michigan that compliance is expected.
Also Friday, the CDC's recommendation changed.
My favorite part: "shared clinical decision-making." ❤️ 🥂
Close second: MedPage again referencing "pregnant women." 😊
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/117567
CDC Panel Stops Endorsing COVID Shots, Pushes for 'Choice'
— RFK Jr.'s committee breaks from flu shot model, leaves it up to individuals to decide
by Terrence Rudd, Staff Writer, MedPage Today
September 19, 2025The CDC's vaccine advisory committee is no longer recommending the COVID-19 shot for specific groups of Americans, but instead stressing shared clinical decision-making in its newest recommendations.
The Advisory Committee on Immunization Practices (ACIP) on Friday unanimously voted 12-0 to update its recommendations for pediatric and adult immunization schedules, but it deviated from recent FDA vaccine approval language by simply calling for "individual-based decision-making" in everyone ages 6 months and older.
For those 6 months to 64 years, this was paired with recommended language that added "an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors."
Until now, the vaccinations had been recommended as a routine step in the fall for nearly all Americans who wanted them -- just like a yearly flu vaccine.
Not everything earned unanimous support during the meeting. A motion to recommend that prescriptions be required to get a COVID vaccine led to a deadlocked 6-6 vote, with ACIP Chair Martin Kulldorff, PhD, formerly of Harvard Medical School in Boston, using his tie-breaking power to kill the proposal.
Panelists worried that the prescription proposal could cut pharmacists -- who administer more than 90% of all COVID shots but can't write prescriptions under Medicare Part B rules -- from the ranks of vaccination providers. The effects could slash access and clog primary care providers' offices, some members cautioned.
A third motion to strengthen discussions with patients about COVID vaccination risks and benefits also earned unanimous 12-0 approval. That recommendation calls for discussion of known risk factors for severe COVID outcomes, including age, prior infections, immunosuppression, and other comorbidities identified by the CDC, as well as "a discussion of the potential benefits and risks of vaccination and related uncertainties, especially those outlined in the vaccine information statement, as part of informed consent."
A fourth recommendation encouraged the CDC to promote more consistent, comprehensive informed consent processes, and to encourage the addition of descriptions of six risks and uncertainties outlined by ACIP member and COVID-19 working group chair Retsef Levi, PhD, of the Massachusetts Institute of Technology Sloan School of Management in Boston. That motion passed on an 11-1 vote.
Kulldorff emphasized that the vaccination schedule recommendations won't affect vaccine access in the Vaccines for Children Program -- the federally run program that covers vaccines for about half of children in the U.S.
Sean O'Leary, MD, of the American Academy of Pediatrics (AAP), said the panel's daylong debate involved clear efforts to "sow distrust" about vaccines and would have "real-time impacts on American children."
But he expressed relief that people could instead follow guidelines from his and other medical groups that still recommend the vaccines be available, like in prior years.
"It was a very, very strange meeting," O'Leary said.
A Festivus of Vaccine Uncertainties
In June, HHS Secretary Robert F. Kennedy Jr. sacked the 17 former members of ACIP and replaced them with members more aligned with his views. During the meeting, new members put plenty of focus on COVID vaccines' perceived unknown risks and uncertain benefits.
The discussion featured contentious topics including alleged DNA alterations by mRNA vaccines and case reports of myocarditis in vaccinated people, assertions that mRNA vaccines don't work as intended, the existence of a post-vaccination syndrome, and potential connections between the vaccines and conditions such as birth defects and cancer.
In a presentation to the panel, CDC COVID-19 workgroup member Henry Bernstein, DO, of the Zucker School of Medicine at Hofstra/Northwell in New York, delivered a stinging dissent to the panel's skeptical tone. The former ACIP member called for continued vaccination coverage for a wide range of populations, including pregnant women, children younger than 2 years, older adults, "and anyone who feels they want protection for themselves and their families."
"If we don't want to say vaccines are 'safe and effective,' well, they work!" Bernstein said.
ACIP, FDA, and Medical Organizations Sing Separate Tunes
Last month, the FDA approved updated COVID vaccines for the 2025-2026 respiratory virus season for all adults 65 and older, but limited their use in younger people and children to those with at least one condition that puts them at high risk for severe disease. Kennedy also announced in May that the CDC had dropped its recommendationopens in a new tab or window that healthy children and pregnant women get routine COVID shots.
Those moves prompted multiple medical organizations to issue their own vaccination recommendations, including the AAP, the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Family Physicians (AAFP), and the Society for Maternal-Fetal Medicine (SMFM). The AAP and AAFP said that all children ages 6 to 23 months should be vaccinated against COVID. ACOG, SMFM, and AAFP also recommended that women who are pregnant at any stage or lactating should get a COVID shot.
Health insurer industry group AHIP released a statement Tuesday that backs ACIP's older, broader COVID vaccination recommendations. "Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing for patients through the end of 2026," AHIP said.
On Friday, the Infectious Diseases Society of America (IDSA) again called for Kennedy to resign.
"His leadership has already put up barriers to many Americans' choice to receive the COVID vaccine," said IDSA President Tina Tan, MD, in a statement. "Now he is attacking routine childhood vaccines that have been given broadly and safely for decades, creating chaos and confusion, taking away parents' choices and putting children's lives at significant risk for severe vaccine-preventable diseases."
Typically, ACIP recommendations must be approved by the CDC director, and are not considered final until they are published in the Morbidity and Mortality Weekly Report.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















